Advertisement

Topics

NICE backs Abraxane for pancreatic cancer regime

04:15 EDT 4 Aug 2017 | thePharmaLetter

Today, UK medicines cost-effectiveness watchdog the National Institute for Health and Care Excellence…

Original Article: NICE backs Abraxane for pancreatic cancer regime

NEXT ARTICLE

More From BioPortfolio on "NICE backs Abraxane for pancreatic cancer regime"

Quick Search
Advertisement